Cleared Traditional

K972689 - CAOW HEMOSTASIS SYSTEM

K972689 is an FDA 510(k) clearance for CAOW HEMOSTASIS SYSTEM, manufactured by Anlam Corp.. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 406-day FDA review.

K972689 · Anlam Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1998
Decision
406d
Days
Class 2
Risk

K972689 is an FDA 510(k) clearance for the CAOW HEMOSTASIS SYSTEM. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Anlam Corp. (Edmonton, Alberta, CA). The FDA issued a Cleared decision on August 27, 1998 after a review of 406 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Anlam Corp. devices

FDA 510(k) Submission Details - K972689

510(k) Number K972689 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 1997
Decision Date August 27, 1998
Days to Decision 406 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
281d slower than avg
Panel avg: 125d · This submission: 406d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 150
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K972689.
FEMOSTOP COMPRESSION ARCH, FEMOSTOP PUMP, FEMOSTOP BILATERAL ADAPTER
K983471 · Radi Medical Systems AB · Feb 1999
EMBOL-X AORTIC OCCLUSION AND CARDIOPLEGIA CANNULA
K980631 · Embol-X, Inc. · Feb 1999
FEMOSTOP II PLUS DISPOSABLE SET MODEL 11166, FEMOSTOP II PLUS COMPRESSION ARCH MODEL 11168, FEMOSTOP II BILATERAL ADAPT0
K982182 · Radi Medical Systems AB · Sep 1998
FLO-THRU
K981624 · Bio-Vascular, Inc. · Aug 1998
BALADI INVERTER WITH COAXIAL AORTIC PUNCH
K980128 · Cardio Medical Solutions, Inc. · Jul 1998
DEGANIA SILICONE IDENTI LOOPS
K981956 · Degania Silicone , Ltd. · Jul 1998